| Parameter |
n(%) |
| Gender |
male 14(45%), female 17(55%) |
| Main site |
|
Lymph node disease only
Lymph node plus other site
Duodenum only |
18(58%)
10(32%)
3(10%) |
| FLIPI |
|
0
1
2
3
4 |
7(23%)
13(42%)
4(13%)
6(19%)
1(3%) |
| Time from diagnosis to 131I-rituximab RIT (months) |
median 39, range2-354 |
| Number of patients given prior treatment |
24(77%) |
| Number of prior lines of therapy |
|
1
2
3 |
13
10
1 |
